stocktrader

Humacyte (NASDAQ: HUMA) stock price has surged hard since I wrote about it in April. It soared to a high of $9.35 on Thursday and is now trading at its highest point since December 2021. It has risen for seven straight weeks and is up by almost 370% from its lowest swing this year. The… Continue reading Humacyte (HUMA) stock price is pumping but 1 key risk remain

GameStop Corp. experienced a temporary trading suspension on Wednesday due to high volatility, as its shares plummeted by 25% shortly after the market opened. The trading halt was a response to rapid fluctuations in the company’s stock price, aimed at stabilizing the market. GME shares continue to decline Trading resumed briefly following the initial suspension,… Continue reading GameStop trading halted twice as GME shares plunge amid high volatility

The prices of precious metals saw an uptick on Wednesday as investors responded to the latest inflation figures from the United States. The annual inflation rate in April slowed to 3.4%, slightly below analysts’ expectations and down from March’s 3.5%. This cooling of inflation has led traders to speculate that the Federal Reserve’s cycle of… Continue reading Gold, silver, platinum prices rise as US inflation cools

Nio Inc (NYSE: NIO) is pushing to the upside in premarket today after William Li – its chief executive was named “EV person of the year”.  Why did Nio CEO win the title? Li was crowned at the 2024 TopGear.com Electric Awards on Monday.  The news arrives shortly after Nio became the first electric vehicle… Continue reading Nio CEO beats Elon Musk to the crown of ‘EV person of the year’

Carnival Corporation’s (NYSE: CCL) shareholders have seen substantial gains, with the stock price rising over 52% in the last year, significantly outperforming the S&P 500’s 22% increase. This surge might make potential investors wonder if they’ve missed the boat on Carnival’s shares, or if the company’s recovery trajectory suggests further growth ahead. The pandemic’s impact… Continue reading Carnival stock has surged, but is CCL still a good buy?

Pfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. However, recent developments suggest a potential turnaround for the pharmaceutical giant. On May 1, 2024, Pfizer reported better-than-expected results for the first quarter of the year. Their non-GAAP earnings per share of… Continue reading Pfizer’s next move: Can it break above $30?